Literature DB >> 26914278

Imaging Early Fate of Cancer Stem Cells in Mouse Hindlimbs with Sodium Iodide Symporter Gene and I-124 PET.

Jin Won Park1,2, Kyung-Ho Jung1,2, Jin Hee Lee1,2, Seung Hwan Moon1, Young Seok Cho1, Yearn Seung Choe1,2, Kyung-Han Lee3,4.   

Abstract

PURPOSE: We investigated the capacity of sodium/iodide symporter (NIS) positron emission tomography (PET) to image and quantitate early engraftment and survival of cancer stem cells (CSCs) in living mice. PROCEDURES: CT26 colon cancer cells and CSCs were infected with an adenovirus expressing both NIS and enhanced green fluorescent protein (EGFP). Cells were implanted into normal and ischemic hindlimbs of mice, and serial optical and I-124 PET imaging was performed. Extracted tissues underwent I-124 measurements and confocal microscopy.
RESULTS: NIS.EGFP gene transfer increased fluorescence and I-124 uptake of CSCs and CT26 cells without adverse effects. I-124 PET clearly visualized implanted tumor cells in vivo, whereas optical imaging was suboptimal. PET revealed 1.95, 2.22, and 1.93-fold greater I-124 uptake by CSC inoculation into ischemic compared to non-ischemic limbs at 2, 15, and 24 h, respectively. CT26 cells showed similar but smaller differences. PET findings were confirmed by ex vivo measurements and confocal microscopy.
CONCLUSIONS: NIS PET can help identify microenvironment conditions that influence early survival of implanted CSCs.

Entities:  

Keywords:  Cancer stem cell; Green fluorescence protein; Hypoxia; Positron emission tomography; Sodium-iodide symporter

Mesh:

Substances:

Year:  2016        PMID: 26914278     DOI: 10.1007/s11307-016-0941-1

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  29 in total

Review 1.  In vivo molecular imaging of cancer stem cells.

Authors:  Yusri D Heryanto; Arifudin Achmad; Ayako Taketomi-Takahashi; Yoshito Tsushima
Journal:  Am J Nucl Med Mol Imaging       Date:  2014-12-15

2.  Hypoxia and lineage specification of cell line-derived colorectal cancer stem cells.

Authors:  Trevor M Yeung; Shaan C Gandhi; Walter F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-02-23       Impact factor: 11.205

Review 3.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

Review 4.  Reporter gene imaging: potential impact on therapy.

Authors:  Inna Serganova; Ronald Blasberg
Journal:  Nucl Med Biol       Date:  2005-10       Impact factor: 2.408

5.  HIF-1α activation under glucose deprivation plays a central role in the acquisition of anti-apoptosis in human colon cancer cells.

Authors:  Arata Nishimoto; Naruji Kugimiya; Tohru Hosoyama; Tadahiko Enoki; Tao-Sheng Li; Kimikazu Hamano
Journal:  Int J Oncol       Date:  2014-04-03       Impact factor: 5.650

Review 6.  Unravelling cancer stem cell potential.

Authors:  Benjamin Beck; Cédric Blanpain
Journal:  Nat Rev Cancer       Date:  2013-10       Impact factor: 60.716

Review 7.  Cancer stem cell markers in common cancers - therapeutic implications.

Authors:  Thomas Klonisch; Emilia Wiechec; Sabine Hombach-Klonisch; Sudharsana R Ande; Sebastian Wesselborg; Klaus Schulze-Osthoff; Marek Los
Journal:  Trends Mol Med       Date:  2008-09-03       Impact factor: 11.951

8.  In vivo imaging, tracking, and targeting of cancer stem cells.

Authors:  Erina Vlashi; Kwanghee Kim; Chann Lagadec; Lorenza Della Donna; John Tyson McDonald; Mansoureh Eghbali; James W Sayre; Encrico Stefani; William McBride; Frank Pajonk
Journal:  J Natl Cancer Inst       Date:  2009-02-24       Impact factor: 13.506

9.  Combined reporter gene PET and iron oxide MRI for monitoring survival and localization of transplanted cells in the rat heart.

Authors:  Takahiro Higuchi; Martina Anton; Katja Dumler; Stefan Seidl; Jaroslav Pelisek; Antti Saraste; Andrea Welling; Franz Hofmann; Robert A J Oostendorp; Bernd Gansbacher; Stephan G Nekolla; Frank M Bengel; Rene M Botnar; Markus Schwaiger
Journal:  J Nucl Med       Date:  2009-06-12       Impact factor: 10.057

10.  Survival of cancer stem cells under hypoxia and serum depletion via decrease in PP2A activity and activation of p38-MAPKAPK2-Hsp27.

Authors:  Shih-Pei Lin; Yi-Ting Lee; Jir-You Wang; Stephanie A Miller; Shih-Hwa Chiou; Mien-Chie Hung; Shih-Chieh Hung
Journal:  PLoS One       Date:  2012-11-20       Impact factor: 3.240

View more
  4 in total

Review 1.  The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.

Authors:  Silvia Ravera; Andrea Reyna-Neyra; Giuseppe Ferrandino; L Mario Amzel; Nancy Carrasco
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 19.318

Review 2.  Advancements in Cancer Stem Cell Isolation and Characterization.

Authors:  Heena Jariyal; Chanchal Gupta; Vedika Sandeep Bhat; Jayant Ramakant Wagh; Akshay Srivastava
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

3.  Reporter PET Images Bortezomib Treatment-Mediated Suppression of Cancer Cell Proteasome Activity.

Authors:  Jin Hee Lee; Kyung-Ho Jung; Cung Hoa Thien Quach; Jin Won Park; Seung Hwan Moon; Young Seok Cho; Kyung-Han Lee
Journal:  Sci Rep       Date:  2018-08-16       Impact factor: 4.379

4.  Targeting poor proteasomal function with radioiodine eliminates CT26 colon cancer stem cells resistant to bortezomib therapy.

Authors:  Jin Hee Lee; Kyung-Ho Jung; Jin Won Park; Seung Hwan Moon; Young Seok Cho; Kyung-Han Lee
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.